| HOME >> BIOLOGY >> TECHNOLOGY |
- Rawson to Oversee Scientific Integrity of WellGen Programs and Advance
Collaborations with Food and Beverage Industry Leaders -
NORTH BRUNSWICK, N.J., Dec. 18 /PRNewswire/ -- WellGen, Inc., a biotechnology company using nutrigenomics to discover and develop food ingredients for wellness products, today announced the appointment of Nancy E. Rawson, M.Sc., Ph.D., as Chief Scientific Officer. Dr. Rawson fills a newly created position that will report directly to the CEO.
Dr. Rawson, 51, joins WellGen at a critical stage in its development, as the Company has just brought its first functional food ingredient product to market and is conducting human studies for its second, while seeking to significantly expand the number of ingredients in its pipeline. In addition, the Company is completing the installation of a new, state-of-the-art molecular biology and natural products chemistry laboratory.
Dr. Rawson comes to WellGen with an extensive background in food, nutrition and basic biomedical research. Dr. Rawson most recently worked at the Monell Chemical Senses Center in Philadelphia, PA, as an Associate Member. The Monell Center is an independent scientific institute dedicated to basic research on the senses of taste, smell and chemosensory irritation. During her tenure there, Dr. Rawson built relationships with well-recognized leaders in the food and beverage industry as well as with researchers throughout the world.
Previously, Dr. Rawson was a Senior Nutrition Research Associate at the Campbell Soup Company. She also has held numerous advisory and university teaching positions.
Dr. Kathleen Mullinix, Chief Executive Officer of WellGen, said, "We
are fortunate to have Nancy Rawson, who is an outstanding scientist, join
our company, and we look to her to ensure that our products' scientific
foundations will meet the very highest standards. Her background in both
research and industry will also enable her to be an eff
'/>"/>
| SOURCE WellGen, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. KGI Names Kerry Howell Vice President for Advancement
2. Vical Names Andrew de Guttadauro Vice President, Corporate Development
3. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
4. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
5. CryoLife Names Philip Theodore as Vice President, General Counsel
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. PPD Names Daniel Darazsdi as Chief Financial Officer
8. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
9. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
10. Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
11. Osprey Pharmaceuticals Names Jack M. Anthony as CEO
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |